Targeted Therapies: Melanoma

Melanoma (January 2015)
Volume: 5
Issue: 1

Melanoma (Sept 2014)
Volume: 3
Issue: 2

Lung Cancer (Sept 2014)
Volume: 2
Issue: 2

Melanoma (May 2014)
Volume: 3
Issue: 1

Melanoma (Sept 2012)
Volume: 1
Issue: 1
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Accepts NDA for Daraxonrasib in Metastatic Pancreatic Cancer
2
Advanced Renal Cell Carcinoma: Tailoring Second-Line Therapy After Prior Immunotherapy
3
FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC
4
Teclistamab/Talquetamab Reduces Risk of Progression by 89% in R/R Multiple Myeloma
5
